A carregar...

Precision Medicines’ Impact on Orphan Drug Designation

The incentives provided under the Orphan Drug Act (ODA) have been credited for catalyzing the marketing approval of drugs for the treatment of rare diseases by the US Food and Drug Administration. Orphan drug designation, the granting of special status to drugs or biologics (“drugs”) for the treatme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Sci
Main Authors: Mueller, Christine M., Rao, Gayatri R., Miller Needleman, Katherine I.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6853264/
https://ncbi.nlm.nih.gov/pubmed/31297924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12667
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!